NCT03612791 2025-06-03ATEZOLACCGustave Roussy, Cancer Campus, Grand ParisPhase 2 Completed189 enrolled
NCT04884906 2021-05-13Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical CancerTianjin Medical University Cancer Institute and HospitalPhase 2 Unknown40 enrolled